DEA Extends Telehealth Flexibilities for Controlled Substance Prescribing Beyond End of PHE
- May 12, 2023
Telehealth flexibilities for prescribing controlled substances to help ensure access during the COVID-19 pandemic remain in place for now despite the Drug Enforcement Administration’s (DEA’s) initial plans to tighten restrictions after the end of the public health emergency (PHE).
ARTICLE TAGS
You must be logged in to access this content.